Saori Sakaue, Accelerating Medicines Partnership®: RA/SLE Network, Jennifer H. Anolik, William Apruzzese, Arnon Arazi, Jennifer L. Barnas, H. Michael Belmont, Celine C. Berthier, Jill P. Buyon, Michelle Curtis, Carla M. Cuda, Maria Dall’Era, Anne Davidson, Betty Diamond, Thomas M. Eisenhaure, Andrea Fava, Jennifer Grossman, Siddarth Gurajala, Joel M. Guthridge, Nir Hacohen, David A. Hildeman, Jeffrey B. Hodgin, Paul J. Hoover, Alice Horsberger, Peter M. Izmirly, Judith A. James, Kenneth C. Kalunian, Diane L. Kamen, Joseph Mears, Maureen A. McMahon, Michael Peters, Michelle A. Petri, Harris Perlman, Chaim Putterman, Deepak A. Rao, Raktima Raychowdhury, Brad Rovin, Fernanda Payan-Schober, Nicholas W. Sugiarto, David Wofsy, E. Steve Woodle, Qian Xiao, Yu Zhao, Soumya Raychaudhuri
Abstract Understanding the genetic regulation of RNA abundance is essential to defining disease mechanisms. However, conventional expression quantitative loci (eQTL) studies quantify RNA molecules across the transcript lifecycle. While most eQTL likely affect transcription by altering promoter or enhancer function within the nucleus, it is also possible that they modulate any processes after transcription, including chemical modifications and RNA stability in the cytosol. To elucidate distinct eQTL mechanisms of early versus late RNA, we compared eQTL from mature cellular RNA and nascent nuclear RNA in the brain and the kidney. Across tissues, we identified different causal variants for cellular and nuclear eQTL for the same eGene . Cellular eQTL were enriched in transcribed regions ( P =3.3×10 -126 ), suggesting the importance of post-transcriptional regulation. Conversely, nuclear eQTL were enriched in distal regulatory elements ( P =7.0×10 -32 ), highlighting the role of DNA transcriptional regulation. For example, we identified stop-gain eQTL variants likely acting through nonsense-mediated decay in cellular eQTL that had no effect in nuclear eQTL. Cellular eQTL were enriched for loci with multiple causal variants in linkage disequilibrium within the transcribed regions, where they may in concert affect RNA stability. We also identified examples of nuclear eQTL variants within enhancers that had no effect in cellular eQTL. We show that such eQTL (e.g., TUBGCP4 ) sometimes uniquely colocalize with disease alleles (schizophrenia). This study reveals key differences in the genetic mechanisms of cellular and nuclear eQTL.